The ImmuTherM research project aims to find new ways to determine the efficacy of immune therapies against malignant melanoma. The project is supported by three Würzburg researchers and their teams: Prof. Dr. Bastian Schilling from the University Dermatology Clinic (UKW), Dr. Niklas Beyersdorf from the Department of Immunology at the Julius Maximilian University (JMU) and Dr. Florian Groeber-Becker from the Fraunhofer Translational Centre for Regenerative Therapies at the Fraunhofer Institute for Silicate Research ISC.

For their investigations, a malignant melanoma model system already developed by the Fraunhofer Translation Centre and UKW will be expanded by further tumour cell lines and human T cells.

The Federal Ministry of Education and Research (BMBF) is funding the joint project with a total of around 830,000 euros over the next three years as part of the "Alternatives to Animal Experimentation" funding programme.

Source and further information:
https://www.uni-wuerzburg.de/aktuelles/einblick/single/news/neue-testsysteme-fuer-krebstherapien/